SAD/MAD Study of a New Formulation of Nebulised RPL554 in Healthy Subjects and COPD Subjects
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the safety of single doses and multiple doses of a new
formulation of RPL554 in healthy subjects and subjects with chronic obstructive pulmonary
disorder.